| WHO - Prequalification of Medical Products (IVDs, Medicines, Vaccines and Immunization Devices, Vector Control)

Renata’s ethinylestradiol/levonorgestrel tabl prequalified

M

23 February, 2024 - 00:12 (CET)

WHO Prequalification Unit (PQT) added the below new p

Merck’s praziquantel prequalified

M

23 February, 2024 - 00:12 (CET)

WHO Prequalification Unit (PQT) added the below new p

First miltefosine prequalified

M

23 February, 2024 - 00:12 (CET)

WHO Prequalification Unit (PQT) added the below new p

First cefiderocol prequalified

M

23 February, 2024 - 00:12 (CET)

WHO Prequalification Unit (PQT) added the below new p

WHO Public Assessment Reports (WHOPARs) published

M

Announcement

23 February, 2024 - 09:51 (CET)

WHO Public Assessment Reports (WHOPARs) published

M

Announcement

20 February, 2024 - 13:33 (CET)

WHO Public Assessment Reports (WHOPARs) published

M

Announcement

29 January, 2024 - 09:20 (CET)

WHO Public Assessment Reports (WHOPARs) published

M

Announcement

26 January, 2024 - 10:33 (CET)

WHO Prequalification Team - Medicines (PQT/MED) note on ePI/mobile technologies for product information (9 January 2024)

M

9 January, 2024 - 14:30 (CET)

Zhejiang Huahai’s nirmatrelvir + ritonavir prequalified

M

18 December, 2023 - 00:43 (CET)

WHO Prequalification Unit (PQT) added the below new product to its prequalified list:

Subscribe to